Title:
A TRIFUNCTIONAL COMPOUND AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/037635
Kind Code:
A1
Abstract:
The present invention pertains to the biomedical field, and particularly relates to a trifunctional compound comprising a fibroblast activation protein (FAP) targeting moiety. The present invention also relates to a pharmaceutical composition comprising the trifunctional compound, and the use ofthe trifunctional compound for diagnosis or treatment of diseases.
Inventors:
LIU ZHIBO (CN)
LIU YU (CN)
LIU YU (CN)
Application Number:
PCT/CN2023/113816
Publication Date:
February 22, 2024
Filing Date:
August 18, 2023
Export Citation:
Assignee:
BOOMRAY PHARMACEUTICALS BEIJING CORPORATION LTD (CN)
International Classes:
C07F5/02; A61K31/69; A61P35/00
Foreign References:
| CN113388004A | 2021-09-14 | |||
| CN114790195A | 2022-07-26 | |||
| CN114369084A | 2022-04-19 |
Other References:
LINDNER THOMAS, LOKTEV ANASTASIA, ALTMANN ANNETTE, GIESEL FREDERIK, KRATOCHWIL CLEMENS, DEBUS JÜRGEN, JÄGER DIRK, MIER WALTER, HAB: "Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein", THE JOURNAL OF NUCLEAR MEDICINE, SOCIETY OF NUCLEAR MEDICINE, US, vol. 59, no. 9, 1 September 2018 (2018-09-01), US , pages 1415 - 1422, XP093139514, ISSN: 0161-5505, DOI: 10.2967/jnumed.118.210443
Attorney, Agent or Firm:
JUN HE LAW OFFICES (CN)
Download PDF: